Homologated aza analogs of arabinose as antimycobacterial agents

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 3, 1998, Pages 237-242

  Maddry, Joseph A ^a   Bansal, Namita ^a   Bermudez, Luiz E ^b   Comber, Robert N ^a   Orme, Ian M ^c   Suling, William J ^a   Wilson, Larry N ^a   Reynolds, Robert C ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b Kuzell Institute for Arthritis and Infectious Diseases   (United States)

^c Immunology and Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; ARABINOSE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REACTION ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ARABINOSE; CELL LINE; HUMANS; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM TUBERCULOSIS;

MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0032477774     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00017-1     Document Type: Article

References (35)

1. 1. Preliminary biological results for some of these compounds were presented as part of the 13th Forum in Microbiology: Maddry, J. A.; Suling, W. J.; Reynolds, R. C. Res. Microbiol. 1996, 147, 106.
2. 2. Arachi, A, Tubercle 1991, 72, 1.
3. 3. (a) Baker, W. R.; Mitscher, L. A.; Arain, T. M.; Shawar, R.; Stover, C. K. Ann. Rep. Med. Chem. 1996, 31, 161;
4. (b) Edlin, B. R.; Tokars, J. I.; Grieco, M. H.; Crawford, J. T.; Williams, J.; Sordillo, E. M.; Ong, K. R.; Kilburn, J. O.; Dooley, S. W.; Castro, K. G.; Jarvis, W. R.; Holmberg, S. D. New Eng. J. Med. 1992, 326, 1514;
5. (c) CDC. Mortal. Morbid Weekly Rep. 1991, 40, 649.
6. 4. (a) Ellner, J. J.; Goldberger, M. J.; Parenti, D. M. J. Infect. Dis. 1991, 163, 1326;
7. (b) Havlik Jr., J. A.; Horsburgh, J. C. R.; Metchock, B.; Williams, P. P.; Fann, S. A.; Thompson III, S. E. J. Infect. Dis. 1992, 165, 577;
8. (c) Murray, J. F. Bull. Int. Union Tuberc. lung Dis. 1991, 66, 21.
9. 5. Lee, R. E.; Brennan, P. J.; Besra, G. S. Curr. Top. Microbiol. Immunol. 1996, 215, 1.
10. 6. Rastogi, N.; Goh, K. S.; David, H. L. Antimicrob. Agents Chemother. 1990, 34, 759.
11. 7. Mikušová, K.; Slayden, R. A.; Besra, G. S.; Brennan, P. J. Antimicrob. Agents Chemother. 1995, 39, 2484.
12. 8. Lee, R. E.; Mikušová, K.; Brennan, P. J.; Besra, G. S. J. Am. Chem. Soc. 1995, 48, 11829.
13. 9. Cohen, N. C.; Blaney, J. M.; Humblet, C; Gund, P.; Barry, D. C. J. Med Chem. 1990, 33, 883.
14. 10. (a) Sinnott, M. L. New Compr. Biochem. 1984, 6, 389;
15. (b) Frische, K.; Schmidt, R. R. Liebigs Ann. Chem. 1994, 297;
16. (c) Joziasse, D. H. Glycobiol 1992, 2, 271.
17. 11. For another example of I-homologated sugars as transferase inhibitors, see: Noort, D.; van Straten, N. C. R.; Boons, G. J. P. H.; van der Marel, G. A.; Bossuyt, X.; Blanckaert, N.; Mulder, G, J.; van boom, J. H. Bioorg. Med. Chem. Lett. 1992, 2, 583.
18. 4 and concentrated to yield 1.53 g (74%) crude, protected sulfone. This material was deblocked in two steps as for 9 to afford 13a.
19. 13. Avigad, G.; Englard, S. Methods Enzymol. 1975, 41, 84.
20. 14. (a) Baxter, E. W.; Reitz, A. B. J. Org. Chem. 1994, 59, 3175;
21. (b) Reitz, A. B.; Baxter, E. W. Tetrahedron Lett. 1990, 31, 6777.
22. 15. Garegg, P. J.; Samuelsson, B. J. Chem. Soc. Perkin Trans. I 1980, 2866.
23. 2-6), 4.66 (bs, 1H, OH-6), 4.98 (d, 1H, OH-3), 5.08 (d, 1H, OH-4), 7.65 (m, 2H, H-3′ & H-5′), 7.75 (m, 1H, H-4′), 7.90 (m, 2H, H-2′ & H-6′).
24. 17. Koerner, T. A. W.; Voll, R. J.; Younathan, E. S. Carbohydr. Res. 1977, 59, 403.
25. 18. Horton, D.; Philips, K. D. Carbohydr. Res. 1973, 30, 367.
26. 25
27. 27
28. 6 Erdman. Four hours later monolayers were washed to remove extracellular bacteria, then incubated for eight days in the presence of a series of dilutions of 11e. Monolayers were lysed and plated on 7H11 agar for three weeks. A TNF response was also performed.
29. 22. (a) Collins, L. A.; Franzblau, S. G. Antimicrob. Agents Chemother. 1997, 41, 1004;
30. (b) Inderlied, C. B.; Nash, K. A. Antimycobacterial Agents: In vitro Susceptibility Testing, Spectra of Activity, Mechanisms of Resistance, and Assays for Activity in Biological Fluids. In Antibiotics in Laboratory Medicine, 4th Ed; Lorian, V., ed.; Williams and Wilkins; Baltimore, 1991; pp 127-175.
31. 23. Reynolds, R. C.; Bansal, N.; Comber, R. N.; Friedrich, J. A.; Rose, J. D.; Suling, W. J.; Maddry, J. A. Ethambutol Derivatives as Putative Inhibitors of Mycobacterial Glycosyltransferases. In preparation.
32. 24. Yajko, D. M.; Madej, J. J.; Lancaster, M. V.; Sanders, C. A.; Cawthon, V. L.; Gee, B.; Babst, A.; Hadley, W. K. J. Clin. Microbiol. 1995, 33, 2324.
33. 25. Heifets, L.; Lindholm-Levy, L. P. Antimicrob. Agents Chemother. 1990, 34, 770.
34. 26. Bermudez, L. E.; Inderlied, C. B.; Kolonoski, P.; Wu, M.; Barbara-Burnham, L.; Young, L. S. Antimicrob. Agents Chemother. 1996, 40, 546.
35. 27. Champsi, J.; Young, L. S.; Bermudez, L. E. Immunology 1995, 84, 549.